logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Epimmune Inc.


USPTO Granted Patents = 17


Forward Citations = 438

Loading Chart...
Loading Chart...

30 inventors (with patents filed for the assignee):

goldMedal Alessandro D Sette (13 out of 42 patents)

silverMedal John Sidney (9 out of 17 patents)

bronzeMedal Scott Southwood (9 out of 12 patents)

4.  Robert W Chesnut (7 out of 15 patents)

5.  Esteban Celis (7 out of 19 patents)

6.  Howard M Grey (7 out of 16 patents)

7.  Brian D Livingston (5 out of 11 patents)

8.  Ralph T Kubo (4 out of 7 patents)

9.  Mark Joseph Newman (4 out of 12 patents)

10.  John D Fikes (3 out of 9 patents)

11.  Jeffery L Alexander (3 out of 5 patents)

12.  Maria A Vitiello (3 out of 4 patents)

13.  Robert W Chestnut (2 out of 2 patents)

14.  Lilia Maria Babe (1 out of 26 patents)

15.  Yiyou Chen (1 out of 12 patents)


17 patents:

1. 9789181 - PAN-DR binding polypeptides and uses thereof (2017-10-17),
2. 9511134 - Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions (2016-12-06),
3. 9340577 - HLA binding motifs and peptides and their uses (2016-05-17),
4. 9266930 - [object Object] (2016-02-23),
5. 9249187 - Pan-DR binding polypeptides and uses thereof (2016-02-02),
6. 8017745 - [object Object] (2011-09-13),
7. 7888472 - Optimized multi-epitope constructs and uses thereof (2011-02-15),
8. 7026443 - Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions (2006-04-11),
9. 6689363 - Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions (2004-02-10),
10. 6602510 - HLA class I A2 tumor associated antigen peptides and vaccine compositions (2003-08-05),
11. 6534482 - Expression vectors for stimulating an immune response and methods of using the same (2003-03-18),
12. 6464980 - MAGE-1 c-terminal immunogenic peptides (2002-10-15),
13. 6419931 - Compositions and methods for eliciting CTL immunity (2002-07-16),
14. 6413935 - Induction of immune response against desired determinants (2002-07-02),
15. 6413517 - Identification of broadly reactive DR restricted epitopes (2002-07-02),
EPIMMUNE INC. is a biotechnology company focused on developing novel immunotherapies for the treatment of cancer and other diseases. With a mission to harness the power of the immune system, EPIMMUNE is conducting cutting-edge research and development to create innovative therapies that target and activate specific immune cells to fight against cancer cells. Through their proprietary technologies and strategic collaborations, EPIMMUNE aims to revolutionize cancer treatment and improve patient outcomes.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

17 Patents

#326 in San Diego, CA

#4,375 in California

#18,331 in US

#34,854 in the World

...
San Diego, CA, United States of America

Epimmune Inc.

Forward Citations = 438

30 inventors:

goldMedal Alessandro D Sette (13 out of 42 patents)

silverMedal John Sidney (9 out of 17 patents)

bronzeMedal Scott Southwood (9 out of 12 patents)

4.  Robert W Chesnut (7 out of 15 patents)

5.  Esteban Celis (7 out of 19 patents)

Please report any incorrect information to support@idiyas.com
Loading…